Abstract
Get full access to this article
View all access options for this article.
References
1.Thermo Fisher Scientific. Thermo Fisher Scientific acquires viral vector manufacturing business from Novasep. 2021 . https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2021/Thermo-Fisher-Scientific-Acquires-Viral-Vector-Manufacturing-Business-from-Novasep/default.aspx (last accessed
January 21 , 2021
).
2.BioMarin Pharmaceutical. BioMarin announces positive phase 3 gene therapy trial results in adults with severe hemophilia A; study met all primary and secondary efficacy endpoints in one-year data set. 2021 . https://investors.biomarin.com/2021-01-10-BioMarin-Announces-Positive-Phase-3-Gene-Therapy-Trial-Results-in-Adults-with-Severe-Hemophilia-A-Study-Met-All-Primary-and-Secondary-Efficacy-Endpoints-in-One-Year-Data-Set (last accessed
January 22 , 2021
).
3.Bayer. Leaps by Bayer leads USD 105 million series B financing in Senti Bio to develop next-generation cell and gene therapies using advanced gene circuit technology platform. 2021 . https://bayer2019tf.q4web.com/news/news-details/2021/Leaps-by-Bayer-Leads-USD-105-Million-Series-B-Financing-in-Senti-Bio-to-Develop-Next-Generation-Cell-and-Gene-Therapies-Using-Advanced-Gene-Circuit-Technology-Platform/default.aspx (last accessed
January 21 , 2021
).
4.LEXEO Therapeutics. LEXEO therapeutics launches with $85 million series A financing to develop gene therapies for rare and non-rare monogenic diseases. 2021 . https://www.globenewswire.com/news-release/2021/01/07/2154828/0/en/LEXEO-Therapeutics-Launches-with-85-Million-Series-A-Financing-to-Develop-Gene-Therapies-for-Rare-and-Non-Rare-Monogenic-Diseases.html (last accessed
January 22 , 2021
).
5.FUJIFILM. Fujifilm to invest $40 million to establish a new state-of-the-art viral vector and advanced therapy process development and manufacturing facility. 2021 . https://www.fujifilm.com/news/n210105_01.html (Last accessed
January 21 , 2021
).
6.bluebird bio. bluebird bio to separate oncology business into independent company. 2021 . https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-separate-oncology-business-independent-company (last accessed
January 22 , 2021
).
7.
Powell
A
. Big step forward for planned center to boost cell- and gene-therapy advances.
The Harvard
Gazette
. 2021. https://news.harvard.edu/gazette/story/2021/01/center-for-cell-and-gene-therapy-to-open-next-year/ (last accessed
January 22 , 2021
).